Armis Biopharma Gains FDA Clearance for VeriFixx Small Bone Implant

Armis Biopharma

Armis Biopharma received FDA 510(k) clearance to market the VeriFixx™ Small Bone Implant for fixation of osteotomies and reconstruction of the lesser toes following correction procedures for hammertoe, claw toe and mallet toe.

VeriFixx is designed to support shorter time to ambulation, shorter overall recovery time and reduced pain.

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us